API Quality & Variability Issues – Page 4

API stability failure during incoming testing – regulatory impact assessment

Symptoms of API stability failure are critical warning signals that must be promptly acknowledged to mitigate risks associated with product quality. Common symptoms include:Click to read the full article.

API assay variability exceeds trend limits during supplier change – CAPA aligned to GMP expectations

The first step in addressing API assay variability is to identify and document the symptoms or signals associated with the issue. Symptoms may manifest as deviations from established assay specifications…

API stability failure during stability studies – preventing batch rejection and recall

Identifying the symptoms or signals of API stability failure is the first step in an effective investigation. API stability failures can manifest in various ways during stability studies, and timely…

Residual solvent excursions during regulatory inspection – CAPA aligned to GMP expectations

Identifying the symptoms and signals that indicate a potential issue with residual solvents is critical in initiating an investigation. Key indicators include:Click to read the full article.

Residual solvent excursions during stability studies – root cause investigation framework

When residual solvent excursions occur, they may manifest as unexpected results in the following ways:Click to read the full article.

Residual solvent excursions during supplier change – preventing batch rejection and recall

Identifying symptoms of residual solvent excursions is critical in preventing further deviation. Symptoms may manifest during routine quality control testing or batch processing and can include:Click to read the full…

Impurity profile drift detected during incoming testing – root cause investigation framework

The first indication of impurity profile drift often arises from routine quality control (QC) during incoming testing of raw materials or APIs. Common signals include:Click to read the full article.

Particle size variability impacts performance during regulatory inspection – CAPA aligned to GMP expectations

Identifying symptoms of particle size variability can often start on the production floor or in the quality control laboratory. Signs of such variability typically include:Click to read the full article.

Impurity profile drift detected during stability studies – root cause investigation framework

Identifying symptoms of impurity profile drift require acute awareness of deviations observed during stability studies. Symptoms may include:Click to read the full article.

Residual solvent excursions during deviation investigation – preventing batch rejection and recall

Identifying symptoms or signals of residual solvent excursions early in the manufacturing process is critical for effective investigation and correction. Some common symptoms to monitor include:Click to read the full…

Impurity profile drift detected during incoming testing – preventing batch rejection and recall

When an impurity profile drift is detected, immediate recognition of symptoms or signals is essential for timely action. Typical indicators may include:Click to read the full article.

API assay variability exceeds trend limits during regulatory inspection – CAPA aligned to GMP expectations

Recognizing the symptoms of assay variability is crucial for a timely response. Symptoms may include:Click to read the full article.